Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 94

1.

Monocyte subpopulations in angiogenesis.

Dalton HJ, Armaiz-Pena GN, Gonzalez-Villasana V, Lopez-Berestein G, Bar-Eli M, Sood AK.

Cancer Res. 2014 Mar 1;74(5):1287-93. doi: 10.1158/0008-5472.CAN-13-2825. Epub 2014 Feb 20. Review.

2.

Influence of the tumor microenvironment on angiogenesis.

Payne SJ, Jones L.

Future Oncol. 2011 Mar;7(3):395-408. doi: 10.2217/fon.11.13. Review.

PMID:
21417903
3.

Targeting tumor micro-environment for design and development of novel anti-angiogenic agents arresting tumor growth.

Gacche RN, Meshram RJ.

Prog Biophys Mol Biol. 2013 Nov;113(2):333-54. doi: 10.1016/j.pbiomolbio.2013.10.001. Epub 2013 Oct 15. Review.

PMID:
24139944
4.

[Research progresses in cancer stem cell and its vascular microenvironment].

Wang J, Deng L, Lu Y.

Sheng Wu Yi Xue Gong Cheng Xue Za Zhi. 2013 Jun;30(3):675-8. Review. Chinese.

PMID:
23865341
5.

Emerging paradigms and questions on pro-angiogenic bone marrow-derived myelomonocytic cells.

Laurent J, Touvrey C, Botta F, Kuonen F, Ruegg C.

Int J Dev Biol. 2011;55(4-5):527-34. doi: 10.1387/ijdb.103228jl. Review.

6.

The role of the tumor microenvironment in regulating angiogenesis.

Watnick RS.

Cold Spring Harb Perspect Med. 2012 Dec 1;2(12):a006676. doi: 10.1101/cshperspect.a006676.

7.

Myeloid cell trafficking and tumor angiogenesis.

Schmid MC, Varner JA.

Cancer Lett. 2007 May 18;250(1):1-8. Epub 2006 Oct 17. Review.

8.

Abnormal tumor vasculatures and bone marrow-derived pro-angiogenic cells in cancer.

Mizukami Y, Sasajima J, Ashida T, Kohgo Y.

Int J Hematol. 2012 Feb;95(2):125-30. doi: 10.1007/s12185-012-1017-x. Epub 2012 Feb 7. Review.

PMID:
22311464
9.

Altered angiogenesis in the tumor microenvironment.

Hida K, Kawamoto T, Ohga N, Akiyama K, Hida Y, Shindoh M.

Pathol Int. 2011 Nov;61(11):630-7. doi: 10.1111/j.1440-1827.2011.02726.x. Epub 2011 Oct 10. Review.

PMID:
22029673
10.
11.

Angiogenesis: from molecular mechanisms to translational implications.

Li B, Xiu R.

Clin Hemorheol Microcirc. 2013;54(4):345-55. doi: 10.3233/CH-121647. Review.

PMID:
23241508
12.

A 'tête-à tête' between cancer stem cells and endothelial progenitor cells in tumor angiogenesis.

Kaur S, Bajwa P.

Clin Transl Oncol. 2014 Feb;16(2):115-21. doi: 10.1007/s12094-013-1103-4. Epub 2013 Aug 27. Review.

PMID:
23979912
13.

Microvesicle-mediated transfer of microRNA-150 from monocytes to endothelial cells promotes angiogenesis.

Li J, Zhang Y, Liu Y, Dai X, Li W, Cai X, Yin Y, Wang Q, Xue Y, Wang C, Li D, Hou D, Jiang X, Zhang J, Zen K, Chen X, Zhang CY.

J Biol Chem. 2013 Aug 9;288(32):23586-96. doi: 10.1074/jbc.M113.489302. Epub 2013 Jun 13.

14.

Novel endogenous angiogenesis inhibitors and their therapeutic potential.

Rao N, Lee YF, Ge R.

Acta Pharmacol Sin. 2015 Oct;36(10):1177-90. doi: 10.1038/aps.2015.73. Epub 2015 Sep 14. Review.

15.

Cancer stem cells switch on tumor neovascularization.

Ping YF, Bian XW.

Curr Mol Med. 2011 Feb;11(1):69-75. Review.

PMID:
21189116
16.

Chapter 15. Methods to study myeloid cell roles in angiogenesis.

Schmid MC, Varner JA.

Methods Enzymol. 2008;445:343-71. doi: 10.1016/S0076-6879(08)03015-2.

PMID:
19022067
17.
18.

New dimensions in vascular engineering: opportunities for cancer biology.

Rabbany SY, James D, Rafii S.

Tissue Eng Part A. 2010 Jul;16(7):2157-9. doi: 10.1089/ten.TEA.2010.0183.

19.

[Microenvironment and colorectal liver metastases angiogenesis: surgical implications].

Lim C, Eveno C, Pocard M.

Bull Cancer. 2013 Apr 1;100(4):343-50. doi: 10.1684/bdc.2013.1725. Review. French.

PMID:
23532039
20.

Hydrogels to model 3D in vitro microenvironment of tumor vascularization.

Song HH, Park KM, Gerecht S.

Adv Drug Deliv Rev. 2014 Dec 15;79-80:19-29. doi: 10.1016/j.addr.2014.06.002. Epub 2014 Jun 23. Review.

Supplemental Content

Support Center